Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.40
0.412.56%
At close: Dec 15, 4:00 PM EST
$16.50
0.100.61%
After Hours: 7:45 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy EyePoint (EYPT) stock?
You can purchase shares of EyePoint (NASDAQ:EYPT) through any online brokerage.
Who are EyePoint (EYPT) competitors?
Other companies in EyePoint’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), Atai Beckley NV (NASDAQ:ATAI), Xeris Biopharma Holdings Inc (NASDAQ:XERS), Phibro Animal Health Corp (NASDAQ:PAHC) and Rapport Therapeutics Inc (NASDAQ:RAPP).
What is the forecast, or price target, for EyePoint (EYPT) stock?
EyePoint has a consensus price target of $30.67.
What is the current price for EyePoint (EYPT)?
The stock price for EyePoint (NASDAQ: EYPT) is $16.5 last updated December 15, 2025 at 7:45 PM EST.
Does EyePoint (EYPT) pay a dividend?
There are no upcoming dividends for EyePoint.
When is EyePoint (NASDAQ:EYPT) reporting earnings?
EyePoint does not have any upcoming earnings scheduled.
Is EyePoint (EYPT) going to split?
There is no upcoming split for EyePoint.
What sector and industry does EyePoint (EYPT) operate in?
EyePoint is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
